NKCFO LLC
CRL icon

NKCFO LLC’s Charles River Laboratories CRL Stock Holding History

NKCFO LLC’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$148K Buy
+500
New +$132K 0.04% 70
2021
Q4 		– Sell
-280
Closed -$116K – 104
2021
Q3 		$116K Hold
280
– – 0.04% 69
2021
Q2 		$104K Buy
+280
New +$93.5K 0.03% 94

Other funds holding CRL

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Cooke & Bieler
Cooke & Bieler Philadelphia, Pennsylvania $6.36B AUM 0.55% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Van Berkom & Associates
Van Berkom & Associates Montreal, Quebec, Canada $2.81B AUM 6.02% 1-Year Est. Return
Boston Trust Walden
Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

NKCFO LLC's CRL Position: Q3 2026 in Review

NKCFO LLC opened a new position in Charles River Laboratories (CRL) in Q3 2026: 500 shares worth $148K. The stake represents 0.04% of the portfolio and ranks #70 among its holdings. This is a return to the name: NKCFO LLC previously reported a position in CRL as recently as Q3 2021.

NKCFO LLC first reported a position in CRL in Q2 2021 and has held it in 3 quarters since. 309 funds tracked by Wall St. Rank hold CRL as of Q3 2026.

  • NKCFO LLC held 500 shares of Charles River Laboratories worth $148K as of Q3 2026.
  • Charles River Laboratories was a new NKCFO LLC position in Q3 2026.
  • Charles River Laboratories made up 0.04% of NKCFO LLC's portfolio in Q3 2026, its #70 holding.
  • NKCFO LLC first reported a position in Charles River Laboratories in Q2 2021 and has held it in 3 quarters since.
  • 309 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.

Based on NKCFO LLC's 13F filing for Q3 2026, filed 4 Nov 2026.